Accelerating Preclinical Imaging Market To Reach $4.83 Billion By 2029, At CAGR Of 6.9%

"
Elated by Advancements in Molecular Imaging and Rising Chronic Diseases, the Preclinical Imaging Market Witnesses Robust Growth

What Is The Projected Market Size Of The Global Preclinical Imaging Market And Its Growth Rate?
• The preclinical imaging market has witnessed significant growth recently, with its value expanding from $3.46 billion in 2024 to $3.69 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.7%.
• The robust growth in the historic period is primarily due to multiple factors including government initiatives, expanding prevalence of diseases, increasing application areas, heightened awareness, and expansion in emerging markets.
• The preclinical imaging market size is projected to continue its strong growth trajectory in the coming years, potentially reaching $4.83 billion by 2029 with a CAGR of 6.9%.
• The future growth can be attributed to factors like the adoption of personalized medicine, advancements in molecular imaging, increasing outsourcing of drug development, supportive regulatory environment, and rising chronic diseases.

What Is Driving The Growth In The Preclinical Imaging Market?
The spike in chronic diseases is a key driver for the preclinical imaging market. Chronic diseases, risky long-term health conditions that last for prolonged periods, require ongoing medical attention and severely impact the quality of life. Chronic diseases are consistently identified using preclinical imaging devices, which provide insights into the bone structure and lung functionality. They are also crucial for chronic disease research to comprehend disease progression. For example, the World Health Organization reported in September 2022 that 74% of all global deaths, or 41 million per year, are caused by Noncommunicable diseases (NCDs) or chronic diseases. Therefore, the increasing instances of chronic diseases prominently impact the growth of the preclinical imaging market.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Who Are the Key Players Driving Preclinical Imaging Market Growth?
Major players in the preclinical imaging market include:
• Thermo Fisher Scientific Inc.
• FUJIFILM Visualsonics Inc.
• Konica Minolta Inc.
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Miltenyi Biotech
• Sofie Biosciences Inc.
• Promega Corporation

What Are The Key Trends In The Preclinical Imaging Market?
Key trends to watch in the forecast period include:
• Adoption of green imaging technologies
• Technological advancements
• A rise in R&D activities
• Collaborations and partnerships
• Real-time imaging

What Are The Segments Of The Global Preclinical Imaging Market?
The preclinical imaging market is segmented as follows:
1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User

Which Region Leads The Preclinical Imaging Market?
Among various geographical regions, North America was the largest player in the preclinical imaging market in 2024. The market report covers multiple regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

What Is Covered In The Preclinical Imaging Market Global Market Report?
- Market Size Analysis: Analysing the Preclinical Imaging Market size by crucial regions, countries, product types, and applications.
- Market Segmentation Analysis: Identifying multiple subsegments within the Preclinical Imaging Market for effective categorization.
- Key Player Focus: Focusing on the key players to ascertain their market value, share, and competitive landscape.
- Growth Trends Analysis: Examining individual growth trends and future prospects in the market.
- Market Contribution: Assessing contributions of varied segments to the overall Preclinical Imaging Market growth.
- Growth Drivers: Elaborating on significant factors dictating market growth, including opportunities, and drivers.
- Industry Challenges: Evaluating challenges and risks impacting the Preclinical Imaging Market.
- Competitive Developments: Analysing competitive developments, like business expansions, agreements, and introduction of new products in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Contact Us
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company:
The Business Research Company, providing over 15,000 reports across 27 industries covering 60 plus geographies, is reputed for its comprehensive, data-intensive research and insights. Aided by over 1,500,000 datasets, in-depth secondary research, and unique industry leader insights, it provides the necessary information for staying ahead. Its top product, the Global Market Model (GMM), is a leading market intelligence platform delivering comprehensive and updated forecasts that support informed decision-making.

This release was published on openPR.